Patents by Inventor Gary P. O'Neill

Gary P. O'Neill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High level expression of human cyclooxygenase-2
    Patent number: 6689596
    Abstract: The invention discloses a cDNA consisting of human cyclooxygenase-2 cDNA attached to 3′ flanking sequence of human cyclooxygenase-1 methods for increasing the expression of human cyclooxygenase-2 in transformed cells and assays for preferentially and independently measuring cyclogenase-2 in samples.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: February 10, 2004
    Assignee: Merck & Co., Inc.
    Inventors: Gary P. O'Neill, Joseph A. Mancini
  • High level expression of human cyclooxygenase-2
    Publication number: 20030032789
    Abstract: The invention discloses a cDNA consisting of human cyclooxygenase-2 cDNA attached to 3′ flanking sequence of human cyclooxygenase-1 methods for increasing the expression of human cyclooxygenase-2 in transformed cells and assays for preferentially and independently measuring cyclogenase-2 in samples.
    Type: Application
    Filed: October 25, 2001
    Publication date: February 13, 2003
    Applicant: Merck Frosst Canada & Co.
    Inventors: Gary P. O'Neill, Joseph A. Mancini
  • High level expression of human cyclooxygenase-2
    Patent number: 6362327
    Abstract: The invention discloses a cDNA consisting of human cyclooxygenase-2 cDNA attached to 3′ flanking sequence of human cyclooxygenase-1 methods for increasing the expression of human cyclooxygenase-2 in transformed cells and assays for preferentially and independently measuring cyclogenase-2 in samples.
    Type: Grant
    Filed: June 21, 2000
    Date of Patent: March 26, 2002
    Assignee: Merck Frosst Canada & Co.
    Inventors: Gary P. O'Neill, Joseph A. Mancini
  • High level expression of human cyclooxygenase-2
    Patent number: 6107087
    Abstract: The invention discloses a cDNA consisting of human cyclooxygenase-2 cDNA attached to 3'flanking sequence of human cyclooxygenase-1 methods for increasing the expression of human cyclooxygenase-2 in transformed cell and assays for preferentially and independently measuring cyclogense-2 in samples.
    Type: Grant
    Filed: September 28, 1998
    Date of Patent: August 22, 2000
    Assignee: Merck Frosst Canada & Co.
    Inventors: Gary P. O'Neill, Joseph A. Mancini